CymaBay Therapeutics to Present at Two Investor Conferences in March
Mar 09, 2017 13:01 pm UTC| Business
NEWARK, Calif., March 09, 2017 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today...
CymaBay Therapeutics to Present at Two Investor Conferences in March
Mar 09, 2017 13:01 pm UTC| Business
NEWARK, Calif., March 09, 2017 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today...
American Airlines Group Reports February Traffic and Record Operational Performance
Mar 09, 2017 13:01 pm UTC| Business
FORT WORTH, Texas, March 09, 2017 -- American Airlines Group (NASDAQ:AAL) today reported February and year-to-date 2017 traffic results. American Airlines Group’s total revenue passenger miles (RPMs)...
American Airlines Group Reports February Traffic and Record Operational Performance
Mar 09, 2017 13:01 pm UTC| Business
FORT WORTH, Texas, March 09, 2017 -- American Airlines Group (NASDAQ:AAL) today reported February and year-to-date 2017 traffic results. American Airlines Group’s total revenue passenger miles (RPMs)...
Fibrocell Reports 2016 Financial Results and Recent Operational Highlights
Mar 09, 2017 13:01 pm UTC| Business
EXTON, Pa., March 09, 2017 -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today reported financial...
Fibrocell Reports 2016 Financial Results and Recent Operational Highlights
Mar 09, 2017 13:01 pm UTC| Business
EXTON, Pa., March 09, 2017 -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today reported financial...
Fortress Biotech to Present at the 29th Annual ROTH Conference
Mar 09, 2017 13:01 pm UTC| Business
NEW YORK, March 09, 2017 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...